| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.47B | 37.24B | 31.33B | 25.82B | 25.31B | 18.78B |
| Gross Profit | 21.16B | 20.60B | 20.16B | 15.56B | 18.77B | 12.26B |
| EBITDA | 18.53B | 20.25B | 23.52B | 17.82B | 17.00B | 10.64B |
| Net Income | 9.83B | 10.49B | 13.55B | 10.20B | 9.99B | 5.98B |
Balance Sheet | ||||||
| Total Assets | 91.77B | 88.14B | 83.64B | 70.34B | 70.92B | 65.83B |
| Cash, Cash Equivalents and Short-Term Investments | 13.69B | 11.12B | 20.08B | 13.87B | 13.17B | 8.77B |
| Total Debt | 35.04B | 34.01B | 13.38B | 12.25B | 15.20B | 13.78B |
| Total Liabilities | 42.78B | 41.73B | 22.02B | 18.75B | 21.90B | 20.06B |
| Stockholders Equity | 42.01B | 39.51B | 54.21B | 44.95B | 41.62B | 37.18B |
Cash Flow | ||||||
| Free Cash Flow | 48.60M | 5.05B | 11.17B | 12.07B | 10.68B | 6.59B |
| Operating Cash Flow | 8.60B | 12.86B | 15.57B | 13.45B | 13.46B | 10.26B |
| Investing Cash Flow | -9.42B | -10.46B | -2.75B | -2.45B | -3.79B | -3.41B |
| Financing Cash Flow | -4.94B | -10.28B | -8.92B | -9.32B | -4.83B | -3.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $5.64B | 19.42 | 52.26% | 4.03% | 1.10% | 3.23% | |
73 Outperform | $13.55B | 16.88 | 58.94% | 4.46% | 20.39% | 16.34% | |
69 Neutral | $4.08B | 17.03 | 17.03% | ― | 12.89% | -1.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | $9.56B | 15.78 | 31.24% | 11.85% | 18.61% | -27.53% |